Eurovet Animal Health
Eurovet Animal Health develops, produces, and markets veterinary pharmaceutical medicines, instruments, and therapeutic nutrition across companion animals, horses, and livestock, selling B2B to veterinary professionals in the Netherlands as part of the Dechra Pharmaceuticals PLC group.
- Company typePrivate
- Founded1978
- HeadquartersBladel, Netherlands
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What Eurovet Animal Health does
Eurovet Animal Health is a veterinary pharmaceutical company operating in the European market. Per the firmographic record, the company was founded in 1978, is headquartered in Bladel, Netherlands, and develops, produces, and markets veterinary pharmaceutical medicines and instruments. The supplied data primarily reflects operations under the Dechra Netherlands banner (formerly AST Farma, integrated into Dechra Pharmaceuticals PLC in 2018), operating in the Dutch market with a portfolio of veterinary pharmaceuticals, instruments, and therapeutic pet nutrition under brands including Vetoryl, Felimazole, SPECIFIC, DuOtic, Lodisure, and Catney One.
The core offering is a therapeutic catalog spanning companion animals, horses, and livestock, with therapeutic coverage in anesthesia, analgesia, antibiotics, endocrinology (Cushing's syndrome, hyperthyroidism), cardiology (feline hypertension), nephrology (chronic kidney disease), dermatology, neurology, ophthalmology, and otology. The technical substrate is conventional veterinary pharmaceutical formulations rather than software or AI-enabled products. Distribution is conducted through a B2B model: a gated webshop (shop.astfarma.nl) and field account managers serve verified veterinary professionals, who in turn prescribe and administer treatments to end animals. Companion educational assets (Dechra Academy eLearning, condition-specific knowledge platforms such as Cushings Connect and Felimazole Connect) extend the offering beyond product sales into professional development.
The revenue model is product sales of pharmaceuticals and therapeutic nutrition to veterinary practices via quote-based pricing — pricing is not publicly disclosed and is gated behind login or direct account-manager engagement. Customer segments are organized vertically by animal type (companion animals as primary, with horses and livestock as secondary). The company competes on brand depth and vet-professional relationships rather than on technology differentiation, and operates within the regulatory framework governing veterinary medicinal products in the European Union.
Eurovet Animal Health firmographics
Firmographics- Name
- Eurovet Animal Health
- Legal name
- Dechra Netherlands
- Website
- https://eurovet.nl
- Company type
- Private
- Founded year
- 1978
- Operating status
- Operating
- Short description
- Eurovet Animal Health develops, produces, and markets veterinary pharmaceutical medicines, instruments, and therapeutic nutrition across companion animals, horses, and livestock, selling B2B to veterinary professionals in the Netherlands as part of the Dechra Pharmaceuticals PLC group.
- Ownership category
- akta.pro rank
Eurovet Animal Health industry classification
Industry- Product category
- Veterinary Pharmaceuticals
- NAICS
- Dog and Cat Food Manufacturing (311111)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Oncology & Specialty Therapeutics (HLAMAEAJ)
- akta.pro secondary industries
- Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB), Veterinary Clinical Nutrition Services & Consulting (HLAMAHAC), Endocrinology & Metabolic Drugs (e.g., Diabetes, Thyroid) (HLAMAEAG)
Keywords
Where Eurovet Animal Health is headquartered
LocationHeadquarters
- HQ city
- Bladel
- HQ country
- Netherlands
- HQ region
- Europe
Markets served
Eurovet Animal Health business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
Revenue model
- Veterinary Pharmaceutical Products: Sale of veterinary medications and therapeutic products across multiple animal segments including companion animals (dogs, cats), horses, and livestock (cattle, poultry, pigs). Products cover therapeutic areas such as anesthesia, analgesia, antibiotics, dermatology, endocrinology, cardiology, and more.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Quote-based pricing for veterinary professionals |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Eurovet Animal Health product offering
Product offeringCore offering
Eurovet Animal Health develops, produces, and markets veterinary pharmaceutical medicines and instruments for companion animals (dogs and cats), horses, and livestock (cattle, pigs, poultry). The portfolio spans therapeutic areas such as anesthesia, analgesia, antibiotics, dermatology, endocrinology, cardiology, nephrology, neurology, ophthalmology, otology, anti-inflammatories, fertility, locomotion, vaccines, and water medication, supplemented by therapeutic pet nutrition under the SPECIFIC brand. Products are sold via veterinary professionals and a B2B webshop.
Product overview
Dechra (formerly AST Farma) offers a comprehensive portfolio of veterinary pharmaceuticals and therapeutic pet food. The product range includes pharmaceutical treatments organized by therapeutic areas (companion animals, horses, and livestock) covering anesthesia, analgesics, antibiotics, anthelmintics, cardiology, dermatology, endocrinology, and inflammation management. The SPECIFIC pet food brand provides therapeutic nutrition for dogs and cats. Notable products include Catney One (phosphate binder for feline CKD), Lodisure (feline hypertension treatment), Felimazole (hyperthyroidism treatment), Vetoryl (Cushing's syndrome treatment), DuOtic (yeast treatment), and Protexin Pro-Fibre Advanced (fiber supplement for dogs). The company serves veterinary professionals through a webshop, pricing lists, and the Dechra Academy eLearning platform.
Differentiator
Problem solved
Functional benefit
Brands
- SPECIFIC: Therapeutic pet food and nutrition products for dogs and cats
- DuOtic
- Catney
- Lodisure
- Felimazole
- Vetoryl
Products and services
- Catney One Phosphate binder for cats with chronic kidney disease (CKD), used by veterinarians to manage phosphorus levels in feline CKD patients.
- Lodisure Veterinary treatment for feline hypertension, prescribed by veterinarians for cats with elevated blood pressure.
- Felimazole (oral solution) Oral solution formulation for the treatment of hyperthyroidism in cats, offering flexible and precise dosing for veterinary prescribers.
- Vetoryl (trilostane capsules) Trilostane capsules for the treatment of Cushing's syndrome in dogs, helping restore vitality, supported by the Cushings Connect knowledge platform.
- DuOtic Otic treatment for yeast infections in companion animals (dogs), administered by veterinarians.
- Protexin Pro-Fibre Advanced Palatable supplementary pet food with high-quality fibers to support physiological intestinal function and functional anal glands in dogs.
- SPECIFIC Nutrition Prescription therapeutic pet food brand for dogs and cats offering diets for kidney problems, high-protein requirements, grain-free diets, and weight management.
Companies that use Eurovet Animal Health
Customer profileSegments4 records
Ideal customer profiles1 record
Eurovet Animal Health technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Eurovet Animal Health partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights4 records
Eurovet Animal Health competitors and assessment
Company assessmentBroad incumbents
- Elanco Animal Health: Elanco is a global animal health leader in companion-animal therapeutics, vaccines and parasiticides, and the larger Bayer Animal Health business. It competes directly with Dechra Netherlands in specialty companion-animal endocrinology, dermatology and anti-infectives.
- Zoetis: Zoetis is the world's largest pure-play animal health company, offering pharmaceuticals, vaccines, diagnostics, and nutrition across companion and livestock species. It is a broad incumbent that competes with Dechra Netherlands across multiple therapeutic categories but operates at significantly greater scale and global reach.
- Dechra Pharmaceuticals PLC: Dechra Pharmaceuticals PLC is the parent group of Dechra Netherlands (formerly AST Farma), operating the global specialty veterinary pharma business now owned by EQT. It is the broader corporate entity that supplies product pipeline, brand assets and capital to the Dutch subsidiary.
- Boehringer Ingelheim Animal Health: Boehringer Ingelheim's animal health division (which absorbed Merial) is one of the world's largest vet pharma players, with overlapping portfolios in vaccines, parasiticides and companion-animal therapeutics, and competes with Dechra Netherlands across most European markets.
Direct peers
- Vetoquinol: Vetoquinol is a France-based veterinary pharmaceutical company operating across Europe and globally with companion-animal and livestock therapeutic portfolios that directly compete with Dechra Netherlands, particularly in Belgium and the Benelux region.
- Virbac: Virbac is a France-headquartered global veterinary pharmaceutical company focused exclusively on animal health, with strong companion-animal therapeutic, parasiticidal and nutrition portfolios that directly overlap Dechra Netherlands' specialty therapeutic offering across European and emerging markets.
- Ceva Santé Animale: Ceva is a global veterinary pharmaceuticals and vaccines company headquartered in France with comparable European commercial presence and overlapping companion-animal, livestock and equine portfolios, making it a closely comparable specialty-focused peer.
- Phibro Animal Health: Phibro Animal Health is a US-headquartered specialty animal health and nutrition company with significant livestock pharmaceutical, vaccine and nutritional specialties portfolios that directly overlap with Dechra Netherlands' landbouwhuisdieren (livestock) segment.
- Orion Corporation (Animal Health): Orion's animal health division is a Nordic-headquartered specialty veterinary pharmaceutical company selling into European markets, with comparable product types (companion-animal therapeutics, particularly Nordic-equine specialty) and similar mid-tier scale to Dechra Netherlands.
Regional players
- Eurovet Animal Health: Eurovet Animal Health is a Netherlands/Germany-focused veterinary pharmaceutical and instruments company appearing in the same firmographic cluster. It is a relevant regional peer for Dechra Netherlands given overlapping product categories in veterinary pharmaceuticals and instruments in the Benelux/DACH markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Eurovet Animal Health social profiles
Digital presenceEurovet Animal Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Eurovet Animal Health leadership team
Management profileNumber of profiles
Eurovet Animal Health funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Eurovet Animal Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Eurovet Animal Health
What does Eurovet Animal Health do?
Eurovet Animal Health develops, produces, and markets veterinary pharmaceutical medicines and instruments for companion animals (dogs and cats), horses, and livestock (cattle, pigs, poultry). The portfolio spans therapeutic areas such as anesthesia, analgesia, antibiotics, dermatology, endocrinology, cardiology, nephrology, neurology, ophthalmology, otology, anti-inflammatories, fertility, locomotion, vaccines, and water medication, supplemented by therapeutic pet nutrition under the SPECIFIC brand. Products are sold via veterinary professionals and a B2B webshop.
Is Eurovet Animal Health a public or private company?
Eurovet Animal Health is a private company. It is classified as corporate owned and is currently operating.
When was Eurovet Animal Health founded?
Eurovet Animal Health was founded in 1978.
Where is Eurovet Animal Health based?
Eurovet Animal Health is headquartered in Bladel, Netherlands, in the Europe region.
How does Eurovet Animal Health make money?
One revenue line is on record: veterinary Pharmaceutical Products.
Who are Eurovet Animal Health's main competitors?
Broad incumbents on record are Elanco Animal Health, Zoetis, Dechra Pharmaceuticals PLC and Boehringer Ingelheim Animal Health. Direct peers are Vetoquinol, Virbac, Ceva Santé Animale, Phibro Animal Health and Orion Corporation (Animal Health). Eurovet Animal Health is listed as a regional player.
Does Eurovet Animal Health have an API?
No public API is recorded for Eurovet Animal Health.
What industry is Eurovet Animal Health in?
Eurovet Animal Health's product category is Veterinary Pharmaceuticals. Its primary akta.pro industry code is HLAMAEAJ, Oncology & Specialty Therapeutics, with a secondary code of HLAMAEAB, Livestock & Production Animal Therapeutics (Rx). Its NAICS code is 311111 and its SIC code is 2834.